兴业证券认为，节前A股跟随海外资产调整后已释放了一定的风险，节后A股即将进入一段高胜率窗 口。此外，国内宏观和产业层面的密集催化对结构上形成指引，继续看好A股在春节后迎来新一轮上 行。 中国银河则提出了春节后重点关注的三条主线。在该机构看来，政策预期、流动性加持与产业趋势催化 下，市场震荡上行概率较大，同时需密切关注海外不确定性对市场情绪的短期扰动。两会前后，A股市 场或将以政策催化为核心驱动力，资金围绕政策导向的产业主线与主题机会博弈，呈现"政策热点轮 动、风格快速切换"的特征。3月市场逻辑将从"政策预期"逐步转向"业绩兑现"，上市公司2025年年报与 随后的2026年一季报披露将成为行情锚点，业绩超预期标的或获得资金聚焦。 （来源：经济参考报） "展望后市，宏观择时方面，我们持续看好A股权益市场。"博时基金权益投资一部总经理曾豪表示，全 年来看，2026年美联储大概率可能持续降息，国内科技产业趋势向上、PPI同比有望回正、叠加人民币 汇率升值预期，有望共同对A股形成有力支撑，马年A股有望延续乐观行情趋势。同时，2026年随着市 场逐步从流动性驱动转向盈利驱动，单一的成长或价值风格难以持续占优，市场主线轮动 ...

2月26日午后，港股医药股加速走低，创新药产业链跌幅靠前，港股通创新药ETF（520880） 、港股通 医疗ETF华宝（159137）双双跌逾2%，场内溢价同步走高，显示"抄底"资金有所行动。 个股方面，权重龙头百济神州跌逾6%居首，据悉，该公司将于今日披露2025年财报。作为创新药领域 龙头企业，百济神州为港股通创新药ETF（520880） 、港股通医疗ETF华宝（159137）持仓股，权重占 比分别为11.27%、2.13%。 开源证券指出，中国创新药正经历从"规模积累"走向"价值释放"的国际化跨越，并持续迎来从"管线预 期"转向"业绩兑现"的商业化收获期。创新药板块已回调两个季度，长期看，较多优质标的估值性价比 明显，当前位置建议加大关注。* 低位埋伏港股医药机遇，借道ETF效率更高，高弹性，T+0！ 投创新药，认准港股通创新药ETF（520880）及其场外联接基金（025221），100%布局创新药研发类 公司，前十大权重股占比超七成，龙头属性突出。 投医疗，选港股通医疗ETF华宝（159137），锚定医疗创新，囊括脑机接口、AI医疗、互联网药店等热 点概念，同时覆盖创新药全产业链龙头。 数据来源：中 ...

招商证券此前表示，节后融资余额有望回流，加上两会前风险偏好有望升温，节后A股资金面有望持续充裕。业绩真空期和政策回暖期给了A股接下来一段 时间进行产业趋势投资创造了良好的环境。 ETF方面，今年1月下半月，A股股票型ETF市场规模曾出现一波快速下降，从4万亿元以上回落至3.1万亿元附近。但自2月以来，股票型ETF市场规模变化重 归平稳。截至2月25日，股票型ETF资产规模报3.18万亿元，持续维持平稳态势。 股票型ETF市场近一年来规模变化 新华财经上海2月26日电（林郑宏）节后开市来的数据显示，A股市场呈现明显回暖态势。截至2月25日收盘，沪指本周累计上涨1.6%，深成指上涨2.66%， 创业板指上涨2.41%，三大股指均稳步走高。A股平均股价则上涨1.62%，报30.07元/股，再度站上30元/股整数关口。 在交投方面，节后首个交易日（2月24日，周二），沪深两市成交额即回到2万亿元上方，报2.2万亿元，周三进一步放大至2.46万亿元，均高于节前最后一周 的平均日成交额（约2.09万亿元）。 杠杆资金节后积极入场股票型ETF资产规模维持平稳 交投活跃背后，是杠杆资金的再度入场。数据显示，节后首个交易日，A ...

自由现金流ETF（159201）及其联接基金（A：023917；C：023918）紧密跟踪国证自由现金流指数， 成分股聚焦高自由现金流率公司，政策红利持续释放叠加市场关注度持续上升，自由现金流ETF （159201）成为投资者资产组合中兼具成长潜力与政策确定性的优质配置选择。基金管理费年费率为 0.15%，托管费年费率为0.05%，均为市场最低费率水平。 每日经济新闻 截至2月26日10点20分，国证自由现金流指数涨0.07%，成分股涨跌互现，烽火通信、盐湖股份、景津 装备等领涨。相关ETF方面，同类规模最大的自由现金流ETF（159201）跟随指数上行，盘中交投活 跃，成交额突破1.6亿元。自由现金流ETF昨日净流入超1.6亿元，近20个交易日净流入超36亿元，资金 布局特征显著。 银河证券研报表示，3月前后，A股市场或将以政策催化为核心驱动力，资金围绕政策导向的产业主线 与主题机会博弈，呈现"政策热点轮动，风格快速切换"的特征。同时，3月市场逻辑将从"政策预期"逐 步转向"业绩兑现"，上市公司2025年年报披露与随后的2026年一季报披露将成为行情锚点，业绩超预期 标的或获得资金聚焦。 ...

Core Viewpoint - The overseas markets showed a slight rebound during the Spring Festival holiday, with U.S. stocks recovering and commodities performing strongly, driven by geopolitical disturbances that significantly increased the prices of oil, gold, and copper. The performance of Chinese assets, particularly the FTSE China A50 index futures, also indicated a positive trend, suggesting a potentially favorable start for the A-share market in the Year of the Horse [2][4]. Group 1: Market Performance and Trends - The overseas non-U.S. assets maintained a strong performance during the holiday, indicating a high risk appetite among overseas investors, which is expected to benefit the A-share market post-holiday [5]. - The inflow of funds into the market remains unchanged, with a notable decrease in household deposits and an increase in non-bank financial institution deposits, suggesting a shift towards equity markets [6]. - Historical data shows that the A-share market typically performs well in the 20 trading days following the Spring Festival, with a 75% probability of the CSI All A Index rising during this period [9]. Group 2: Sector Focus and Investment Opportunities - The focus for investment should be on sectors benefiting from AI and resource commodities, with a particular emphasis on the robotics and AI technology applications showcased during the Spring Festival [13][14]. - The traditional sectors such as real estate and liquor are expected to see a recovery as their valuations are at historical lows, supported by improving fundamentals and policy catalysts [11]. - The "反内卷" (anti-involution) policy is anticipated to enhance the supply dynamics of resource commodities, making them attractive for investment [11]. Group 3: Strategic Recommendations - Investors are advised to focus on the technology sector, particularly in robotics and AI applications, as well as cyclical sectors like chemicals, construction materials, and machinery, which are expected to benefit from rising prices and improved demand [15]. - The market is entering a configuration phase where "technology + cyclical" remains the main theme, with technology sectors likely to respond first to market catalysts [15].

Group 1 - The Hong Kong stock market experienced a significant rise on February 23, with the Hang Seng Index increasing by 2.53%, the Hang Seng China Enterprises Index by 2.65%, and the Hang Seng Tech Index by 3.34% [1] - Major stocks such as Zijin Mining, Meituan, and SMIC led the gains, each rising over 5%, while Tencent and Alibaba increased by more than 3% [1] - During the Chinese New Year holiday, the Hang Seng Index saw a cumulative increase of 1.94%, with the China Enterprises Index up by 1.82% and the Tech Index by 0.47% [1] Group 2 - The AH share premium index fell by 2.34% to 113.68 points, marking the lowest level since July 2, 2018, influenced by the strong performance of the Hong Kong market [1] - As of February 23, there were nine stocks with H shares trading at a premium to their A shares, including CATL with a premium exceeding 31% and others like China Merchants Bank and WuXi AppTec with premiums over 10% [1] - Market analysts believe that the positive performance of the Hong Kong market during the holiday may provide a boost to the A-share market post-holiday, with several brokerage firms optimistic about A-share performance [1]

重点留意！节后三大翻倍方向，重仓股民拿稳别慌！ 春节的瓜子还没嗑完、拜年的红包还没理清楚，重仓的股民朋友心早就飞回A股盘面了。有人攥着筹码 怕洗盘，有人盯着行情怕踏空，有人刷着研报找主线，整个人又期待又忐忑。 最近市场信号越来越清晰，节后行情正在悄悄蓄力，三大方向被政策、资金、业绩三重加持，多家正规 券商研报直接点名"具备翻倍级修复空间"。到底是画饼噱头，还是真金白银的机会？重仓的朋友该守还 是该跑？ 2026年2月13日，上证指数收盘4082.07点，沪深两市成交19826.8亿元。 数据来源：上海证券交易所、深圳证券交易所官网行情中心。 市场不缺钱，央行直接送上"定心丸"，官方公告可查。 2026年2月13日，央行开展10000亿元买断式逆回购操作，期限182天。 中长期活水直达市场，为节后行情筑牢资金底座。 经济基本面也在回暖，国家统计局数据实打实。 2026年1月CPI同比上涨0.2%，核心CPI同比上涨0.8%，消费稳步修复。 PPI同比降幅连续收窄，工业端持续回暖，企业盈利预期向上。 三重利好打底，节后不是瞎炒，是有支撑的结构性机会。 重仓的朋友先别慌，下面这三大方向，就是机构紧盯的翻倍主线。 第 ...

Core Viewpoint - The article discusses the current funding logic in the market, highlighting the significant movements of public funds in the technology sector, particularly in the semiconductor and biopharmaceutical industries, as they adjust their portfolios based on performance and valuation metrics [3][8]. Group 1: Public Fund Movements - Public funds have shown a notable shift in their holdings, particularly in the STAR Market, with the STAR 50 Index rising by 12.1% this year [3][4]. - The total market capitalization of STAR Market companies reached 10.4 trillion yuan, with the technology sector dominating, accounting for 62.1% of the total market cap [5][6]. - The semiconductor industry remains the core focus for fund allocation, with 12 companies in the sector having a market capitalization exceeding 10 billion yuan [9][11]. Group 2: Semiconductor Sector Insights - The market's pricing anchor for the semiconductor sector has shifted from "valuation expansion" to "performance realization," emphasizing the importance of actual earnings [13][14]. - Key drivers for future growth in the semiconductor sector include strong order backlogs, profit growth through acquisitions and expansions, and sustained price increases in advanced processes [13][14]. - Public funds have significantly increased their holdings in semiconductor materials, chip design, and equipment, with companies like ShenGong Co. seeing an 11% increase in fund holdings [15][21]. Group 3: Biopharmaceutical Sector Insights - The biopharmaceutical sector is a critical area for public funds, with major holdings in companies like BeiGene and United Imaging Healthcare, although the sector has faced a reduction in holdings for several key companies [24][26]. - The article notes that innovative drug companies are currently under pressure, with significant reductions in holdings observed in companies like BaiLi TianHeng and RongChang Biopharma [26][28]. - Despite the challenges, companies with strong earnings potential and innovative drug pipelines are still attracting interest from public funds, indicating a selective investment approach [35][40].

Stock Performance - The stock of Weichai Heavy Machinery (000880.SZ) experienced a decline of 3.67% on February 13, closing at 35.67 yuan, with a trading volume of 631 million yuan and a turnover rate of 7.72% [1] - The stock had previously risen significantly, with a 5-day cumulative increase of 11.47% and a 20-day increase of 19.34%, indicating a potential overbought condition [1] Capital Flow - On February 13, there was a net outflow of 99.03 million yuan in main funds, including a net outflow of 63.79 million yuan from large orders and 35.25 million yuan from super large orders [2] - The financing balance decreased by 10.75 million yuan over the past 5 trading days, suggesting that some leveraged funds are taking profits [2] Sector Performance - On the same day, the automotive parts sector fell by 0.64% and the machinery equipment sector dropped by 0.96%, both underperforming the broader market, which saw the Shanghai Composite Index decline by 1.26% [3] Company Valuation - The current price-to-earnings ratio (TTM) for the company is 67.45, significantly higher than the industry average of 43.17, while the price-to-book ratio stands at 8.04, near historical highs [4] - Despite a projected net profit growth of 45%-75% for 2025, there are concerns regarding the company's ability to meet high valuation expectations [4] - The recent stock movement is attributed to a combination of technical overbought conditions, capital outflows, and weak sector sentiment, although the company's fundamentals remain strong with long-term support from projected earnings growth and alternative fuel technology initiatives [4]

Group 1 - The stock price of Victoria's Secret (VSCO.N) has recently adjusted, closing at $56.82 on February 11, with a single-day decline of 4.05% and a cumulative drop of 6.67% over the past five trading days [1] - The stock experienced a volatility of 6.10% on the same day, with a trading volume of approximately $66.79 million and a turnover rate of 1.45% [1] - The retail sector in the U.S. faced pressure from February 10 to 11, with the Dow Jones index declining by 0.11% and the Nasdaq index by 0.13%, which may have affected individual stock sentiment [2] Group 2 - The Q3 2025 financial report of the company showed a year-over-year revenue growth of 9.2% to $1.472 billion, and the adjusted earnings per share loss narrowed to $0.27 [2] - The current price-to-earnings ratio stands at 26.68, which is higher than some peers, indicating potential market disagreement regarding valuation [2] - Since January 2026, the proportion of buy/hold ratings from institutions has remained stable at 50%, but the average target price of $62.67 reflects about a 10% gap from the current stock price, suggesting a cautious market outlook on performance realization [3]